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There are numerous reports in the literature on the infectivity and viru-
lence  of  human  influenza  A  virus1 and  the histopathological  response  to
infection in several species of animals, particularly mice and ferrets.  There
is,  however, lack of  satisfactory information  on the rapidity and extent  of
increase  of  the virus relative  to  the dosage  of  the inoculum  and  the lung
lesions  and mortality produced.
Smorodintseff  and  Ostrovskaya  (3)  were  the first  to point  out that fol-
lowing intranasal inoculation of mice with lethal doses, the maximum con-
centration of the virus in the lungs was reached in 24 to 48 hours, although
at  this  interval  no  macroscopic  lesions  were  manifest.  The  amount  of
virus in the inoculum was not always precisely given  nor did these authors
determine the increase  of the virus following  inoculation  of sublethal doses.
It  has been established that with a  "fixed"  strain the virus content of a
suspension  may  be  rather  accurately  measured  by  its  lethal  effect  upon
mice  inoculated  intranasally  and that through  serial  dilution  a point  can
be reached  where lung lesions  are produced  but  the mice  survive  (4).
This paper embodies  the results of  studies on the titration  of  the virus
in the lungs and the macroscopic lung lesions and mortality in mice at vary-
ing intervals following the administration  of graded doses of the virus, and
the effect  of intranasal  instillation  of fluid  following infection  with a  sub-
lethal dose.
Material  and Methods
Virus.-The virus strain  PR8 was used  throughout  these  experiments.  This strain
which has been  through 333 mouse passages  was chosen because its virulence to mice is
well fixed  and it is  possible  to  prepare  dilutions  that  will  give predictable  results  in
respect  to  mortality  and  production  of  lung lesions.
1 Name  suggested  by  Horsfall,  Lennette,  Rickard,  Andrewes,  Smith,  and  Stuart-
Harris (1) for the virus discovered by Smith, Andrewes,  and Laidlaw  (2).
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Infected  mouse  lungs  were  ground in  a porcelain  mortar  with a  small  quantity of
alundum sand.  A 20 per cent suspension by weight of the ground mouse lungs was made
in  broth containing  20 per  cent normal horse  serum and  the  whole centrifuged  for  15
minutes at 2500 R.P.M.  The supernate was withdrawn  and stored in a low temperature
cabinet at  - 76 0C.  (5).  This stock suspension had been titrated each week for a number
of months and was found to have an average  50 per cent mortality titer of 10-6 5. Dilu-
tions between  10- 7and 10- 8 usually produced lesions  but the mice survived.  This virus
stock  was  employed  for infecting  all mice.  The  required  dilutions  were  made  imme-
diately  before use  in broth containing  10 per cent normal horse serum.
Titration of Virus  Content of Mouse Lungs.-Groups of  four  mice  were  sacrificed  at
varying  intervals  following  inoculation  and  the  lungs  removed  aseptically.  After  in-
spection for lesions, the lungs were mixed, weighed, and ground in a mortar with alundum
sand.  A primary 10 per cent suspension  of the lung pulp was made and centrifuged  for
10 minutes  at 2500  R.P.M.  Serial  tenfold dilutions  were  prepared  from  the supernate.
10 per cent normal horse serum in broth was used as diluent.
Groups of  four mice were  inoculated intranasally  while under light ether anesthesia
with  each  dilution  tested.  Each  mouse  received  0.05  cc.  The mice  were kept under
observation, and all dying were autopsied for verification of the characteristic pulmonary
consolidation  of viral infection.  At the conclusion of  10 days, all surviving  mice were
autopsied  and the lung  lesions  noted.
The  titration  end-point  was based  on  50 per cent mortality  calculated  according  to
the  formula  of  Reed  and  Muench  (6).
EXPERIMENTAL
Groups  of  mice were  inoculated  intranasally with varying  amounts  of virus ranging
from  less  than  1/10  to more than  300,000  M.L.D.
2 At intervals following  inoculation,
four mice from each group were sacrificed and the lungs titrated for virus content.  The
results are  shown in Table I and Fig. 1.  The base line in the figure  represents  1 M.L.D.,
and the first series of points to the left shows the log of the number of M.L.D.  inoculated.
The succeeding points on each lineal diagram indicate the log of the observed content  of
M.L.D. per  mouse  lung at varying intervals following  inoculation.
The macroscopic lung lesions in the mice sacrificed for titration are recorded in Table
II.  Previous titrations of the virus suspension used for inoculation had amply demon-
strated that 31  M.L.D.  or more were consistently fatal, and that 0.06 M.L.D.  though usually
producing  some pulmonary  lesions  failed to  cause  death.
It  will be  observed that:  (a)  When the dose  of  virus administered was
large,  the  maximum  titer  was  reached  within  24  hours.  (b)  Although
the  proportional  increase  following  smaller  doses  was  greater  during  the
first  24  hours,  the  maximum  titer  was  not reached  until  48  hours.  (c)
In each instance  the maximum  titer was attained before the appearance of
gross lesions  in the lungs.  (d)  When  a lethal  dose was administered,  the
M.L.D.  content of the lungs approached  log +7  and remained in this neigh-
borhood  until death  ensued.  But with the sublethal  inoculum  the  M.L.D.
2  M.L.D.  refers to minimum  lethal dose  when inoculated intranasally.
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FIG.  1.  Lung content  of  virus at varying  intervals  following  intranasal inoculation
of graded doses.  Plotted  logarithmically  according  to  M.L.D.
TABLE  I
Lung Content of  Virus at Varying Intervals Following Intranasal  Inoculation of Graded
Doses.  Expressed in Log and Actual Number (Antilog) of M.L.D.
Minimal  lethal doses
Log  Number  Log  Number  Log  Number  Log  Number
Inoculum. .................................  -1.2  0.06  +1.5  31 +3.5  3,100 +5.5  310,000
Virus content  of lung after  day ..........  +3.04  1,100  +5.88  760,000 +6.88  7,600,000 +6.71  5,130,000
Virus content of lung after  2 days .........  4.88 76,000  +7.04  11,000,000  +6.88  7,600,000 +6.88  7,600,000
Virus content of  lung after 3  days .......... +4.88  76,000  +6.88  7,600,000 +6.88  7,600,000+6.38  2,410,000
Virus content of lung after 4 days ..........  +4.88  76.000
Virus content of  lung after 5 days ......... +4.8  76,000  +6.88  7,600,000
Virus content of lung after 7 days  .......... +4.7151,400
Virus content of lung after 10  days . ........  +2.12  130
content did not exceed  log  +4.9.  (e)  However,  within  48 hours following
the  sublethal  dose,  the  virus had  increased  more  than  1,000,000  times.
At this interval the lungs of one of  these mice  contained  sufficient  virus toEXPERIMENTAL  INFLUENZA  A  INFECTION  IN  MICE
infect fatally  76,000 normal mice, yet the mouse whose lungs harbored this
enormous  amount  of  virus in  some  way  managed  to master  the infection
and survive.  Nor  did the virus  further increase  after it reached  a maxi-
mum at 48  hours following  inoculation.
Repeated  experiments have shown that the amount  of virus in the lungs
of mice receiving  a sublethal dose was always less than in mice which had
TABLE  II
Lung Lesions in Mice Inoculated Intranasally  with Graded Doses of Virus and Sacrificed
at Varying Intervals  for Titration of Virus Content of Lungs*
M.I.D.linoculated
Log
+5.5
+3.5
+1.5
-1.2
Number
310,000
3,100
31
0.06
Days after inoculation
1 2
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D indicates  death and the number of pluses the degree of lesion.
* Only the lungs of living mice were used for titration.
t Atypical.
received  a fatal  inoculum.  The  crucial  titer  appears  to be  around  10-6;
that  is, mice  which  have been  given  a fatal  dose  and are  destined  to  die
will, at 48 hours following  inoculation, have  a lung titer above  10-,  while
in mice  which  received  a sublethal  dose and  consequently  would  survive,
the titer was usually below this level.
Having  found  that  the  lungs  of  sublethally  infected  mice  contained
several hundred M.L.D.  within 24 hours and many  thousand within 48 hours
following inoculation, we decided to see what effect the instillation of  a few
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additional  M.L.D.  would  have.  With this object  in view  the following ex-
periment  was performed.'
A series  of mice was inoculated  intranasally with 0.06 M.L.D.  and on the Ist, 2nd, 3rd,
4th, 5th,  7th, and 10th days  following  the  sublethal inoculation,  ten mice of the series
received intranasally  31  M.L.D.  of virus.  At the  same periods an equal  number of the
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FIG.  2.  Effect of intranasal instillation of 31 M.L.D.  (PR810-5)  of virus and 10 per cent
normal horse serum in broth at varying intervals after infection with a sublethal dose of
virus,  0.06  M.L.D.  (PR810-7'7).  All  mice  survived  which  received  only  0.06  M.L.D.
(pR8107.7).
series received  10 per cent normal horse serum in broth, which  was the diluent used for
the virus.  These were intended as controls upon inoculation of the virus.  In addition
a In this and  the succeeding  experiments the quantity of 0.05 cc. per mouse was used
for intranasal instillation.  The mice were  held for observation for at least  10 days fol-
lowing the last instillation, and all  dying during this period were  autopsied for verifica-
tion of lung consolidation.  Also, all surviving mice were  autopsied and the lung lesions
recorded.  Mice which failed to show typical lung consolidation at time of death are not
included  in  the  protocols  of the  experiments.EXPERIMENTAL  INFLUENZA  A  INFECTION  IN  MICE
ten mice received no intranasal instillation  beyond  the original inoculum  of 0.06  M.L.D.
As anticipated,  none  of the  latter ten  succumbed;  but as  will be seen in Fig.  2, which
illustrates  the  percentage  mortality  following  the  secondary  instillations,  most  of the
mice died that received the relatively small addition of virus during the first 5 days follow-
ing the  original  inoculation.  There  was  a decline  in  the  mortality  among  the  group
reinoculated  on  the  7th  day,  and  by the  10th  day following  the original  sublethal  in-
oculum immunity to 31  M.L.D.  of virus was almost  complete.
In interpreting  these  results  it should  be borne  in mind that  the mice
subinoculated  between  the  2nd  and  5th days  already had  in their  lungs
between  50  and  100,000  M.L.D.  from  which  they  would  have  recovered,
yet the administration  of 31  M.L.D.  caused them to die.
It was still more surprising to find that many of the mice which received
an instillation of sterile  10 per cent normal horse  serum in broth also died.
While  the mortality  was  low  among  the groups  receiving  the instillation
on the 1st and 2nd days, it rose to nearly 90 per cent among those receiving
the  instillation  on  the 4th day  following  sublethal  infection.  Thereafter
the  effect,  as judged  by mortality,  diminished until  by the  10th  day  the
mice  were  completely  resistant.
The  lungs of  the mice which died  following  either  the instillation of  31
M.L.D.  of  virus or  10 per  cent  normal horse  serum  in broth  presented  the
characteristic  consolidation  of  virus infection.  Moreover,  deaths  did not
begin to occur until 3 or 4 days following  the secondary instillations,  which
is about the interval required  for a heavy dose of virus to cause death.
An  additional  number  of  mice  was  included  in  this  experiment  and
sacrificed at intervals  for titration  of virus content  of the lungs.  The re-
sults are shown in Fig.  3.  It will be seen that following the instillation  of
either 31  M.L.D.  of virus or 10 per cent normal horse serum there was within
24 hours  a  sharp  increase  in  virus  titer  above  that observed  in  the  sub-
lethally  infected  mice  which  received  no  subsequent  treatment.  The
apparent  severe  drop  in  titer  on the  2nd  day  after  administration  of  10
per cent  normal horse serum  may be related  to the element  of chance  in-
volved in  choice  of mice  sacrificed  for the titration.  Only  two of the ten
mice  retained  in  this group  subsequently  died.  It  is probable,  therefore,
that the amount of virus in a suspension prepared from the pooled  lungs of
four mice  would be  influenced by  whether  there happened  to  be a  mouse
among  the four which  would later  have died.  Indeed one of  the  striking
features  of this phenomenon  is that the mice either die or the  course of the
disease is apparently  unaffected.  The  results  are probably  influenced  by
both the stage of the infection and the success in flooding the lungs with the
subsequent  instillate.
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A number of experiments  were  made  using  various bland fluids  for  in-
stillation.  The results of  one of these  experiments  are recorded  in Fig. 4,
in which each square  on the histograms represents  a mouse.
All of the mice as in the previous experiment first received an intranasal inoculation  of
0.06  M.L.D.  of virus.  4 days thereafter  groups  of ten  of these  mice  were  given intra-
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FIG.  3.  Effect on virus  titer in lungs of intranasal instillation  of 31  M.L.D.  (PR81° )
of virus and 10 per cent normal horse serum in broth 24 hours after infection with a sub-
lethal dose  of virus (0.06  M.L.D.).
FIG. 4.  Effect of intranasal instillation of various fluids on 4th day after infection with
a sublethal  dose of virus  (0.06  .L.D.).
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nasally sterile distilled  water,  0.425,  0.85, and  1.7  per cent NaCl solution,  10 per cent
normal goat  serum,  and  10  per cent  serum from  a goat  immunized against  influenza
virus,4 respectively.  A  group  of ten  mice  was also  held  as controls.  This  group  re-
ceived no subsequent instillation  but was placed under light ether anesthesia  on the 4th
day, in  order to  control the  effect  of  the anesthesia  which  was  used for  all intranasal
instillations.
It  will  be  observed  that  varying  proportions  of  the  mice  died  with
typical  lesions  in  the  groups  receiving  distilled  water,  graded  concentra-
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FIG.  5.  Effect  on virus  titer in lungs  of intranasal  instillation  of  10 per cent normal
and 10 per cent immune serum on 4th day after infection with a sublethal dose of virus.
tions of  NaCl,  and  10 per  cent normal  goat serum,  but  all in the  control
group, as well  as all which  received  10 per cent  immune  serum, survived.
It  is doubtful that the differences  in mortality among the groups  receiv-
ing  distilled  water,  NaCl  solutions,  and  10  per  cent  normal  serum  are
significant,  for,  as has been pointed out,  there appears  to be a certain ele-
ment of  chance  involved  in  the  results of  the secondary  instillations.  It
seems clear, however, from this and other experiments, that immune serum
4  This goat serum  was prepared  by the intratracheal inoculation  of  a mouse lung sus-
pension of active virus (7) and had a "standard  titer" (8) of 1:512.
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blocks or  offsets  the  usually  fatal  effect  of fluids  such  as distilled  water,
saline,  and normal serum  solutions.
Again,  additional  mice  were  included  in  the  groups  receiving  normal
serum  and  immune  serum  and  in  the  control  group  for  titration  of the
virus content of  the lungs.  The results  of  the titrations  are illustrated  in
Fig.  5.  The  height  of  the  titer at  the  time  the  instillations  were  given
was higher than was commonly encountered in mice receiving this quantity
of virus.  However,  as will be noted  in Fig.  4,  none of  the control group
held for observation  succumbed  from  the infection.  Following  the instil-
lation of normal serum the titer rose and remained above what is considered
to  be  the  crucial  level.  On  the other  hand,  the  titer  of  the  group  re-
ceiving immune  serum declined  in parallel with the control group.
Histopathology.-In order  to  follow  the  histopathological  processes,  at
daily intervals  sections  were  prepared  of  the lungs of  mice  receiving  0.06
M.L.D. of virus, of  the lungs of  the same series  of mice after the intranasal
instillation of 0.85 per cent NaCl solution on the 4th day following the sub'
lethal infection,  and for purposes of comparison,  of the lungs of mice which
had received graded lethal doses of virus.
The pathological changes following infection with a fatal dose were found to be similar
to those  described  by  Straub  (9,  10),  Nelson  and  Oliphant  (11),  de Balogh  (12),  and
others.  The outstanding  features were  a swelling of the bronchial  mucosa followed  by
degeneration  and desquamation  of  the  cells  leading  frequently  to  a  plugging  of  the
bronchioles which was superseded by dilation and then collapse of the alveoli with edema,
congestion, and not uncommonly  extravasation  of  blood  in the alveolar  spaces.  Peri-
bronchial  infiltration  of mononuclear  cells  was  found in  varying  degrees.  Death was
apparently  due  to collapse  of the alveoli  and  the resulting  cessation  of lung function.
In the lungs of  mice sublethally  infected  the process was much  retarded and limited in
extent.  Although  after the  1st or 2nd day,  there was some indication of thickening  of
the  bronchial  mucosa,  the  cells  were  apparently  intact,  and  the nuclei  retained  their
normal staining qualities.  By the 5th to the 7th day there was observed patchy desqua-
mation  which  was followed  by a very  marked  hyperplasia with  the  conversion  of the
columnar  to  stratified epithelium.  At this time parts of the lung were  emphysematous
and other  portions beginning  to  collapse,  but  the collapsed  pneumonic  areas never  be-
came extensive and resolution  soon followed.  Here and there the peribronchial infiltra-
tion  was quite marked.
However, within 24 to 48 hours after the instillation of the saline solution the picture
was markedly  altered and the lungs began  to present  an appearance  quite analogous to
that observed in  the mice which had received  many lethal doses of the virus.  By the
4th day  the mice began  to die with lungs completely  consolidated by alveolar  collapse,
edema, and  congestion.  Straub  (10)  remarks in  his more recent  paper, which came to
attention after this work was in progress, that the intranasal administration  of Tyrode's
solution  1 to 2 days following  inoculation of a "weak" virus  enhanced  the pathological
changes.
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DISCUSSION
Several questions emerge  from these  experiments which  provoke  discus-
sion.  Why is it that a mouse can have within  24 hours following infection
several hundred, and within 48  hours many thousand, fatal  doses of virus
in  its lungs  and yet  survive?  Why  is it that a  small quantity  (0.05  cc.)
of  fluid  instilled into the lungs  of  a mouse  infected  with a  sublethal dose
of  virus will  cause a  rapid increase  of  the virus  and usually death  within
3 to  8 days?  Also,  how  is  it  that immune  serum  which  ordinarily  has
little  effect  after the infection  is once  implanted  prevents  this deleterious
action?  The following postulates which embody ideas expressed  by others
(13)  would  offer  an  explanation  for  these  phenomena.
When a virus particle becomes  associated with a cell, it proceeds to mul-
tiply to the supporting  capacity  of the infected  cell.  It would  also  seem
that for some reason it is easier for the virus to enter or to become attached
to the  cell than  to escape it; that is,  the  cell acts in the manner of  a trap,
as well  as a haven, for the virus.  The injury inflicted by the virus is pri-
marily confined  to the attacked cell, and the death  of the host occurs only
when a sufficient proportion  of the cells of a vital organ have been affected
to  prevent  the  essential  functioning  of  that  organ.  In  the  case  of  the
influenza virus it is probably  the damage  to the mucosa of the bronchioles
which produces  occlusion  and the resulting  fatal pneumonia.
The  channel  of  dissemination  of  the influenza  virus  is largely  through
the  bronchial  tree  rather  than  through  the  blood  or  lymphatic  system.
This conception  seems justified  by the fact  that the  virus  is  confined  al-
most  exclusively  to  the lungs and  the  difficulty  of producing  fatal  pneu-
monia  by  any  other  than  through  the  intranasal  route  of  inoculation.
More  than  100,000  intranasal  M.L.D.  may be  given  intraperitoneally  and
at least 20,000 M.L.D.  given  intravenously without  the production of a fatal
pneumonia.
In the course of infection immunity of neutralizing  antibodies against the
influenza  virus  develops  rather  rapidly.  The action  of  immune  serum  is
mainly  upon  virus  which  is  outside  of  or  has  escaped  from  the  cell.  It
will,  therefore,  prevent the virus from passing from one cell to another  al-
though it has a very limited effect,  if any, upon virus protected by the  cell.
This would  explain how it is possible  for a mouse  receiving  a sublethal
inoculum  to develop  rapidly  a large  quantity  of  virus  and  harbor  it  for
some  days  and still  recover.  It would  seem that the mouse  does  not die
because  an insufficient  number  of  cells  have  been  infected  by  the  initial
inoculum,  and by the time  the virus begins  to escape  in any  considerable
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quantity  from the  infected  cells  it is  prevented  from entering  additional
cells by the presence of neutralizing  antibodies which in the interval  have
begun to appear.  Thus, while  an enormous  stock  of virus has been pro-
duced and is retained,  possibly within the infected  cells, a balance is estab-
lished between the liberation of the virus and the production  of antibodies.
In  consequence  the infection  is prevented  from spreading  to  the required
number  of  cells  to produce  a  fatal  pneumonia.  This  would  also  explain
the differential between the virus titer of the lungs of mice receiving a lethal
and  sublethal  dose,  the  virus titer  being  proportional  to  the  number  of
cells  primarily  infected.
It  is readily conceivable  that the introduction  of  some unnatural  influ-
ence which  would  tend to favor the escape  of the  virus from  the infected
cells or its spread through the bronchial tree would upset what is probably
a rather delicate balance and result in the invasion of cells that would have
otherwise  escaped.  This is probably what happens  when fluid  is instilled
into the nose of a sublethally  infected  mouse.  That the effect  is attribut-
able  to the dissemination  of  the virus rather  than to  direct  injury of  the
pulmonary  cells per se is  supported  by:  (a)  the rise in  the virus titer,  (b)
the occurrence  of deaths only after an interval  of  3 to 8 days,  (c) the his-
topathological  picture  which  resembles  that of  lungs  of  mice  having  re-
ceived  a  lethal  inoculum  of  the  virus,  and,  lastly,  (d)  the  fact  that  the
effect  is  not produced  if  a  dilution  of  immune  serum  instead  of  normal
serum  is used for the instillation.  The physical  properties  of  10 per cent
immune  serum  are  no  different  from  those  of  a  like  solution  of  normal
serum and presumably  would cause  the same insult to the lung tissue.  It
is believed,  therefore,  that the reason for the failure  of the immune serum
to bring  about  death is that it neutralizes  the virus  as the latter escapes
and thus prevents  the invasion  of additional  cells.
Although it is dangerous  to venture far in the realm of  speculation, one
cannot avoid the thought that there may be an analogy between the deaths
induced  in sublethally  infected  mice  by the intranasal  instillation  of  fluid
and  the influenzal  pneumonias  of  human  beings.  It  is  conceded  that in
nearly all of the fatal  influenzal  pneumonias  seen in man there  is a super-
vening bacterial infection, and the secondary bacterial invasion is generally
believed  to  be  the  immediate  cause  of  death.  On  the  other hand,  is  it
justifiable to conclude  that the influenza  virus only paves the way for the
bacteria  and  that  the  latter  are  entirely  responsible  for  the  final issue?
May  it  not  be  that,  in  keeping  with  the  hypothesis  above  propounded,
the  inflammation  induced  by the  bacteria  causes,  like the  intranasal  in-
stillation of fluid in mice, an excessive release of the virus and that the virus
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then  spreads  and  invades  new  cells?  According  to this  conception,  the
sequence  of  events  would  be  as  follows:  primary and  in  all probability
sublethal  virus  infection  with  a breaking  down of  the barrier  to bacterial
invasion,  the  bacteria  in  turn  causing  an  excessive  release  of  the  virus
from the cells, and finally both the virus and  the bacteria contributing  to
the  terminal  pneumonia.  Such  a  procession  would  explain  the  rather
singular  pathology  of  influenzal  pneumonias  which  presents  a  certain
uniformity in appearance  irrespective  of the type of the secondary invader.
Instillation of fluid after infection  (sterile salt solution, broth, or 10 per
cent serum)  may prove of assistance  in adapting  influenza virus strains to
mice.  The  procedure  has not  yet been  adequately  tried,  but  thus  far  it
has  been  found  that  infection  could  be  more  readily  established  with
two strains relatively  avirulent for mice  if the mice were  given intranasal
instillation  of broth on the 2nd day following inoculation.
SUMMARY
Following  intranasal  inoculation  of  influenza  A  virus  (strain  PR8)
there  is a rapid  increase of  the  virus in  the lungs  which with large  doses
reaches  a maximum  within  24  hours.  With smaller  doses, although  the
proportional increase is greater, the maximum concentration is not reached
until 48 hours  following inoculation.  If a lethal dose is administered,  the
ultimate  concentration  of  the virus  in the lungs  is  the same,  irrespective
of the size of the dose.
If a sublethal dose  is given, the titer  of the virus  in the lungs does not
achieve the titer reached  in mice  receiving a lethal dose.  Within 48 hours
following  inoculation  of a sublethal dose the lungs of  a mouse may contain
at least  76,000 M.L.D.,  yet the mouse  survives.
The intranasal  instillation  of  sterile  fluid  (distilled  water,  varying con-
centrations  of  NaCl,  broth,  or  10  per  cent  normal  serum)  into  a  mouse
sublethally  infected  produces a sharp rise in  the virus  content of the lung
usually  followed  by death  within  3 to  8  days.  If, however,  the instillate
consists of 10 per cent immune serum, there is no rise in the virus titer, and
no  apparent harm results from the instillation.
The  implications of  these  phenomena are  discussed  and  an hypothesis
presented  to  explain  their  occurrence.
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